Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
City of Hope Medical Center
ImmunityBio, Inc.
M.D. Anderson Cancer Center
Incyte Corporation
Sotio Biotech Inc.
NeoTX Therapeutics Ltd.
GlaxoSmithKline
Cancer Research UK
Salubris Biotherapeutics Inc